(MedPage Today) — The FDA approved mitapivat (Aqvesme) as a disease-modifying treatment for anemia in adults with alpha- or beta-thalassemia, a rare inherited blood disease that affects hemoglobin production.
An oral pyruvate kinase (PK) activator…
Source link : https://www.medpagetoday.com/hematologyoncology/anemia/119194
Author :
Publish date : 2025-12-24 17:19:00
Copyright for syndicated content belongs to the linked Source.
